Your shopping cart is currently empty

Lactacystin is an orally active, irreversible, and cell-permeable proteasome inhibitor (IC50 = 4.8 μM) that also inhibits the lysosomal enzyme cathepsin A. It induces apoptosis and cell cycle arrest, possesses anticancer, antiviral, and antioxidant activities, can penetrate the blood-brain barrier, and is commonly used in the construction of Parkinson’s disease and dementia models.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μg | $123 | - | In Stock | |
| 100 μg | $197 | - | In Stock | |
| 1 mg | $847 | - | In Stock |
| Description | Lactacystin is an orally active, irreversible, and cell-permeable proteasome inhibitor (IC50 = 4.8 μM) that also inhibits the lysosomal enzyme cathepsin A. It induces apoptosis and cell cycle arrest, possesses anticancer, antiviral, and antioxidant activities, can penetrate the blood-brain barrier, and is commonly used in the construction of Parkinson’s disease and dementia models. |
| Targets&IC50 | Proteasome:4.8 μM |
| In vitro | Methods: RA-differentiated SH-SY5Y cells were treated with lactacystin (2.5–10 μg/ml, 48 hours) to select the effective concentration for celastrol studies. Results: Lactacystin at a concentration of 10 μg/ml (26.4 μM) reduced SH-SY5Y cell viability by 40-50%. [3] |
| In vivo | Methods: Lactacystin (5 μg/2 μl) was administered unilaterally into the left SNc of rats to study its effect on rat body weight. Results: Lactacystin can reduce the body weight of rats. [3] |
| Molecular Weight | 376.43 |
| Formula | C15H24N2O7S |
| Cas No. | 133343-34-7 |
| Smiles | C(SC[C@H](NC(C)=O)C(O)=O)(=O)[C@@]1([C@H](C(C)C)O)[C@@H](O)[C@@H](C)C(=O)N1 |
| Relative Density. | 1.367 g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 18 mg/mL (47.82 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.